A decreasing trend was also observed for antibodies against selected EBV cross-reactive human proteins (septin-9, dihydrolipoamide S-succinyltransferase).
← all excerpts
Experimental Therapies in Multiple Sclerosis: Epstein-Barr Virus and Potential EBV-Related Therapeutic Strategies-A Systematic Review.
1
—
—